Answers are grounded in this paper and cite their sources.
The metabolic syndrome (MetSy), which is defined by the spectrum of obesity, insulin resistance and dyslipidaemia, is recognised as a major contributor to the overall risk of developing cardiovascular disease. Intermittent fasting (IF), which encompasses dieting plans with varying schedules of fasting, may be an effective method of reducing the burden of MetSy and the consequent cardiovascular events in the face of a worsening obesity epidemic in the contemporary society.
No takes yet. Share an insight, caveat, or question.
Gavaghan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: